BRIEF-Astrazeneca, Immunocore tie-up to conduct immuno-oncology trials

* Medimmune unit entered into collaboration to conduct clinical trials in immuno-oncology with privately-held immunocore limited
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.